IBDEI2GU ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,41819,0)
 ;;=M87.012^^159^2010^42
 ;;^UTILITY(U,$J,358.3,41819,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41819,1,3,0)
 ;;=3^Idiopathic Aseptic Necrosis of Left Shoulder
 ;;^UTILITY(U,$J,358.3,41819,1,4,0)
 ;;=4^M87.012
 ;;^UTILITY(U,$J,358.3,41819,2)
 ;;=^5014659
 ;;^UTILITY(U,$J,358.3,41820,0)
 ;;=M87.050^^159^2010^43
 ;;^UTILITY(U,$J,358.3,41820,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41820,1,3,0)
 ;;=3^Idiopathic Aseptic Necrosis of Pelvis
 ;;^UTILITY(U,$J,358.3,41820,1,4,0)
 ;;=4^M87.050
 ;;^UTILITY(U,$J,358.3,41820,2)
 ;;=^5014679
 ;;^UTILITY(U,$J,358.3,41821,0)
 ;;=M87.051^^159^2010^44
 ;;^UTILITY(U,$J,358.3,41821,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41821,1,3,0)
 ;;=3^Idiopathic Aseptic Necrosis of Right Femur
 ;;^UTILITY(U,$J,358.3,41821,1,4,0)
 ;;=4^M87.051
 ;;^UTILITY(U,$J,358.3,41821,2)
 ;;=^5014680
 ;;^UTILITY(U,$J,358.3,41822,0)
 ;;=M87.052^^159^2010^41
 ;;^UTILITY(U,$J,358.3,41822,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41822,1,3,0)
 ;;=3^Idiopathic Aseptic Necrosis of Left Femur
 ;;^UTILITY(U,$J,358.3,41822,1,4,0)
 ;;=4^M87.052
 ;;^UTILITY(U,$J,358.3,41822,2)
 ;;=^5014681
 ;;^UTILITY(U,$J,358.3,41823,0)
 ;;=M87.111^^159^2010^74
 ;;^UTILITY(U,$J,358.3,41823,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41823,1,3,0)
 ;;=3^Osteonecrosis d/t Drugs,Right Shoulder
 ;;^UTILITY(U,$J,358.3,41823,1,4,0)
 ;;=4^M87.111
 ;;^UTILITY(U,$J,358.3,41823,2)
 ;;=^5014701
 ;;^UTILITY(U,$J,358.3,41824,0)
 ;;=M87.112^^159^2010^71
 ;;^UTILITY(U,$J,358.3,41824,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41824,1,3,0)
 ;;=3^Osteonecrosis d/t Drugs,Left Shoulder
 ;;^UTILITY(U,$J,358.3,41824,1,4,0)
 ;;=4^M87.112
 ;;^UTILITY(U,$J,358.3,41824,2)
 ;;=^5014702
 ;;^UTILITY(U,$J,358.3,41825,0)
 ;;=M87.150^^159^2010^72
 ;;^UTILITY(U,$J,358.3,41825,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41825,1,3,0)
 ;;=3^Osteonecrosis d/t Drugs,Pelvis
 ;;^UTILITY(U,$J,358.3,41825,1,4,0)
 ;;=4^M87.150
 ;;^UTILITY(U,$J,358.3,41825,2)
 ;;=^5014722
 ;;^UTILITY(U,$J,358.3,41826,0)
 ;;=M87.151^^159^2010^73
 ;;^UTILITY(U,$J,358.3,41826,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41826,1,3,0)
 ;;=3^Osteonecrosis d/t Drugs,Right Femur
 ;;^UTILITY(U,$J,358.3,41826,1,4,0)
 ;;=4^M87.151
 ;;^UTILITY(U,$J,358.3,41826,2)
 ;;=^5014723
 ;;^UTILITY(U,$J,358.3,41827,0)
 ;;=M87.152^^159^2010^70
 ;;^UTILITY(U,$J,358.3,41827,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41827,1,3,0)
 ;;=3^Osteonecrosis d/t Drugs,Left Femur
 ;;^UTILITY(U,$J,358.3,41827,1,4,0)
 ;;=4^M87.152
 ;;^UTILITY(U,$J,358.3,41827,2)
 ;;=^5014724
 ;;^UTILITY(U,$J,358.3,41828,0)
 ;;=M87.180^^159^2010^69
 ;;^UTILITY(U,$J,358.3,41828,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41828,1,3,0)
 ;;=3^Osteonecrosis d/t Drugs,Jaw
 ;;^UTILITY(U,$J,358.3,41828,1,4,0)
 ;;=4^M87.180
 ;;^UTILITY(U,$J,358.3,41828,2)
 ;;=^5014741
 ;;^UTILITY(U,$J,358.3,41829,0)
 ;;=M87.311^^159^2010^168
 ;;^UTILITY(U,$J,358.3,41829,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41829,1,3,0)
 ;;=3^Secondary Osteonecrosis,Right Shoulder
 ;;^UTILITY(U,$J,358.3,41829,1,4,0)
 ;;=4^M87.311
 ;;^UTILITY(U,$J,358.3,41829,2)
 ;;=^5014788
 ;;^UTILITY(U,$J,358.3,41830,0)
 ;;=M87.312^^159^2010^165
 ;;^UTILITY(U,$J,358.3,41830,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41830,1,3,0)
 ;;=3^Secondary Osteonecrosis,Left Shoulder
 ;;^UTILITY(U,$J,358.3,41830,1,4,0)
 ;;=4^M87.312
 ;;^UTILITY(U,$J,358.3,41830,2)
 ;;=^5014789
 ;;^UTILITY(U,$J,358.3,41831,0)
 ;;=M87.350^^159^2010^166
 ;;^UTILITY(U,$J,358.3,41831,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41831,1,3,0)
 ;;=3^Secondary Osteonecrosis,Pelvis
